The inhibitor κB kinase-β (IKK-β) phosphorylates the NF-κB inhibitor protein IκB leading to the translocation of the transcription factor NF-κB to the nucleus. The transcription factor NF-κB and consequently IKK-β are central to signal transduction pathways of mammalian cells. The purpose of this research was to develop a 3D structural model of the IKK-β kinase domain with its ATP cofactor and investigate its dynamics and ligand binding potential. enzyme. Based on the overall structural flexibility, it is suggested that a truncated version of the kinase domain from Ala14 to Leu265 should be subjected to crystallisation trials.
Introduction
The inhibitor κB kinase-β (IKK-β, IKBKB, IKK2) is a key enzyme in the activation pathway of the transcription factor NF-κB. IKK-β phosphorylates the NF-κB inhibitor protein IκB leading to its ubiquitinylation and degradation as reviewed by Schmid & Birbach (2008) . NFκb is then translocated to the nucleus, where it stimulates the transcription of genes. IKK-β and subsequent NF-κB activation occurs due to a variety of inflammatory stimuli including viral and bacterial pathogens (Chu et al., 1999) . Changes in IKK-β regulation have also been linked to various forms of cancer (Bollrath and Greten, 2009; Hernandez et al., 2010; Karin and Greten, 2005) , heart disease (Gupta et al., 2008; Konia et al., 2009) and to the development of type II diabetes (Arkan et al., 2005) . Recently IKK-β has been characterised as a novel drug target against influenza virus infection. The known low affinity inhibitor aspirin (Yin et al., 1998) was shown to protect mice from influenza infection, when inhaled prior to virus exposure, and, most importantly, it did not induce virus resistance in multipassaging experiments (Mazur et al., 2007) . The high mutation rate of influenza virus proteins causing the development of resistance against the existing M2 proton channel inhibitors (Barr et al., 2008; Barr et al., 2007) and neuraminidase inhibitors (Handel et al., 2007; Yen et al., 2006) lead to the proposal of IKK-β as novel drug target of the host cell against influenza infection (Ludwig and Planz, 2008) .
IKK-β exists as part of a complex consisting of two catalytic subunits, IKK-α (also known as IKK1), IKK-β and a regulatory subunit IKK-γ (NEMO); they predominantly exist as IKK-α/IKK-β heterodimer associated with IKK-γ (Krappmann et al., 2000) . Although IKK-α and IKK-β have overall 52% sequence identity and >70% homology (Burke and Strnad, 2002; Woronicz et al., 1997) , IKK-β is the essential enzyme for phosphorylation of IκB (Delhase et al., 1999) , since cells lacking IKK-α show normal induction of NF-ĸB DNA-binding activity in response to most stimuli and pathogens (Chu et al., 1999; Delhase et al., 1999) .
The human IKK-β sequence is 756 amino acid residues long and has a molecular mass of 86.6 kDa (DiDonato et al., 1997; Woronicz et al., 1997) . It consists of a kinase domain (residues 15-312), a leucine zipper domain (458-479), a helix-loop-helix domain and the IKK-γ binding domain (734-744) (Mercurio et al., 1997) . Activation of IKK-β requires phosphorylation of Ser177 and Ser181 (Lallena et al., 1999) , and more recently Tyr188 and Tyr199 were identified as necessary for activation (Darwech et al., 2010a; Huang et al., 2003) , while the phosphatases PPM1A and PPM1B play a role in deactivation (Sun et al., 2009 ).
Despite the pronounced interest into IKK-β as a drug target, because of its central role in a key signal transduction pathway, no experimental 3D structure is available. However, some models of the kinase domain based on comparative modelling have been published (Avila et al., 2009; Lauria et al., 2010; Mathialagan et al., 2010; Nagarajan et al.) , but the 3D structures are not available either in public databases or from the authors of the studies. It appears that in most of these studies straightforward comparative modelling using the BLAST algorithm for template selection and the automated Modeller (Eswar et al., 2008) or the Swiss-Model (Guex et al., 2009) server was used for model building. Crucially, the co-factor ATP normally located in the active site was not included in most studies, apart from the study by Avila et al. (Avila et al., 2009 ), which developed a comparative model based on one template with the 'first approach mode' of the Swiss-Model server. It has been suggested that comparative models, which include the natural ligand, can lead to similar and in some cases to better results for protein-ligand docking, than crystal structures without the ligand (Rockey and Elcock, 2006) .
In this study we report the comparative model of the IKK-β kinase domain based on multiple templates including the ATP co-factor and Mg 2+ ions. The resulting model was refined through molecular dynamics (MD) simulations using a simulated heating/annealing protocol in an explicit water environment. Our results reveal model accuracy, which is superior to some of the structural templates used in terms of model assessment parameters. In order to identify small-scale conformational changes and novel allosteric binding sites the model was subjected to constant temperature MD simulations over 80 ns. While simulations of this time scale are too short to reveal large conformational changes or even protein folding events, it was shown that this time scale is sufficient to explore the conformation of loops and sidechains in agreement with experimental data (Almond et al., 2007; Nederveen and Bonvin, 2005) . Our results reveal the molecular details of ATP and peptide substrate ligand binding, the role of the activation loop and conformational changes. This study will facilitate virtual screening and rational drug design efforts for this biomedically important protein kinase.
Materials and methods
The computations were performed on a dual-socket dual-core AMD Opteron workstation (Digital Networks UK, Hyde) and a cluster build from 80 two-socket quad core Intel Xeon E5520 nodes (Dell Inc., USA).
Template selection and alignment
The primary sequence of human IKK-β was retrieved from UniProtKB (Apweiler et al., 2010; Jain et al., 2009) (Fiser and Sali, 2003; Sali and Blundell, 1993) software with an rms_cutoff=3.5, gap_penalties_1d=(-450, -50), gap_penalties_3d=(0,3) and the alignment_type='progressive'.
Homology modelling and model assessment
The homology model of the IKK-β kinase domain was generated by the Modeler9v7 (Fiser and Sali, 2003; Sali and Blundell, 1993) program using the cofactors ATP and Mg 2+ during the modelling process. Initially 100 models were generated, with a thorough optimisation using the variable target function method (automodel.library_schedule = autosched.slow) with a maximum number of conjugate gradient iterations of 300, followed by a slow refinement with simulated annealing molecular dynamics (automodel.md_level = refine.slow).
Initially the models were assessed based on the normalised Discrete Optimized Protein
Energy (Shen and Sali, 2006 ) (DOPE) scores. Ten models with the lowest DOPE score were selected and further rated with MolProbity (Chen et al., 2010) . The MolProbity score was highlighted as a good measure of the protein-likeliness in an analysis of all-atom accuracy of models from the Critical Assessment of Protein Structure Prediction (CASP8) exercise (Keedy et al., 2009) . The model with the lowest MolProbity score and suitable peptide backbone dihedral angles as reported by by Ramachandran plot analysis (Lovell et al., 2003) was selected.
An all-atom model was generated by adding hydrogen atoms with the HAAD algorithm (Li et al., 2009) , which was reported to have a higher accuracy than the widely used program REDUCE (Word et al., 1999) .
System preparation
All the energy minimisations (EM) and molecular dynamics (MD) simulations were performed with the GROMACS 4.07 simulation package (Hess et al., 2008) employing the AMBER03 force field (Duan et al., 2003) ported to GROMACS (DePaul et al., 2010; Sorin and Pande, 2005) . AMBER03 is a variant of the AMBER99 force field, which was successfully used for many all-atom protein MD simulations (Cerutti et al., 2010; Ponder and Case, 2003) . The standard AMBER building blocks were used to build the topology, except for ATP. The atomic charges of ATP 3-were obtained with the RESP ESP Charge Derive (Dupradeau et al., 2010) and provided by François-Yves Dupradeau (personal communication). The AMBER topology for Gromacs was generated from the Tripos MOL2
format with the ACPYPE web portal (http://webapps.ccpn.ac.uk/acpype/) that includes Antechamber (Wang et al., 2006) . The protein/ATP/Mg system was solvated with 9723 TIP3P water (Mahoney and Jorgensen, 2000) molecules and neutralised with one Na + ion that replaced a water molecule at the position of favourable electrostatic potential. The charges on the protein were chosen automatically in accordance with a pH of 7.0.
The energy of the system was minimised with 2000 steps of the conjugate gradient method, while keeping the protein and ATP heavy atoms restrained to their original positions.
Lennard-Jones interactions were calculated with a cut-off of 1.4nm, while electrostatic interactions were treated with the Particle-Mesh-Ewald method using a real space cut-off of 1.0 nm.
In the next step 500 ps of MD simulations with position restraints on the protein and ATP non-hydrogen atoms were performed. A time step of 2 fs was used at a temperature of 298K, kept constant via a stochastic velocity rescaling thermostat (Bussi et al., 2009 ) using a coupling constant of 1.0 ps. Isotropic Berendsen pressure coupling (Berendsen et al., 1984) with a time constant of 1.0 ps was applied to keep the pressure constant at 1.0 bar. Covalent bonds of the protein and the ATP were constrained with the LINCS algorithm (Hess et al., 1997) , while water molecules were constrained with the SETTLE algorithm (Miyamoto and Kollman, 1992) . Long-range dispersion corrections for energy and pressure were applied.
After a further 2000 steps of conjugate gradient energy minimization without any position restraints the system was subjected to unrestrained MD simulations.
Simulated heating/annealing MD (SAMD)
SAMD of the unrestrained system was performed, by heating from 20K to 280K over a period of 4000 ps and annealing from 280K to 20K for another 4000 ps. All other parameters were as described above. Afterwards the system was subjected to 2000 steps of conjugate gradient energy minimization. The same SAMD/EM protocol was repeated twenty times with different random initial atom velocities. The ensemble of twenty structures was analysed with respect to the root mean square deviation (RMSD) of the peptide backbone atom coordinates with the g_cluster program of the GROMACS 4.07 package. The final SAMD model was chosen as the central structure, i.e. the structure that was most similar to all other structures of the ensemble.
Constant temperature MD simulations
The final model with ATP/Mg 2+ bound was subjected to MD simulation at a temperature of 298K over a period of 80 ns. All other parameters were as described above. For the MD simulation of the protein without ATP, the ATP/Mg coordinates were deleted and the system was subjected to 2000 steps of conjugate gradient energy minimisation followed by 500 ps of MD simulations with position restraints on the protein non-hydrogen atoms. After a further 2000 steps of energy minimisation the unrestrained MD simulation was run over a period of 80 ns. Tow repeat simulations for each system were run over a period of 50 ns.
The trajectory between 10 ns and 80 ns was analysed for clusters of similar structures using the g_cluster tool of the GROMACS software package with a cutoff of 0.3 nm and the Gromos clustering algorithm (Daura et al., 1999) . The pdb-files of central cluster structures are available as supplementary material.
Binding site prediction
Binding sites of the final model were predicted by computational solvent docking, in which a library of small organic probe molecules was docked to the protein without ATP/Mg 2+ using the FTmap algorithm . It was shown that a cluster of probes found by
FTmap can identify important subsites of a protein binding site and that a group of vicinal clusters can map out a protein binding site with high accuracy .
Accession numbers
The final model after the SAMD protocol was submitted to the Protein Model Database (Castrignano et al., 2006) and is available under the identifier PM0076858.
Results and discussion

Template identification & multiple sequence alignment
Templates were identified with HHpred (Hildebrand et al., 2009) , which utilises the pairwise comparison of profile hidden Markow models that provides superior sensitivity and selectivity compared to sequence-profile based methods like PSI-BLAST. From almost 800
protein serine/theronine kinase structures available in the RCSB protein databank (Berman et al., 2000) the HHpred algorithm identified the best 100 structural templates with sequence identities ranging from18% to 31%. Five templates were chosen, namely 3G51A (31% sequence identity), 3FE3A (31% sequence identity), 3HKOA (30% sequence identity), 3DTCA (30% sequence identity) and 1ZY4A 29% sequence identity). Inaccuracies in comparative modelling can arise through large gaps (Lushington, 2008) , where the target sequence is not covered by any structural template. In order to avoid these inaccuracies a further template 1PHK with 27% sequence identity was selected that covered all gaps in the alignment. For an accurate description of the ATP binding site it is necessary to include ATP in the modelling process, which was found in the template 1RDQE (27% sequence identity).
The resulting structure/sequence alignment obtained from the Modeller SALIGN procedure is shown in figure 1(a) shaded according to similarity scores based on the BLOSSUM62 matrix (Henikoff and Henikoff, 1992) . Except for the first eleven N-terminal residues there is a good coverage of the query sequence by at least one of the templates. Another region of low sequence similarity is in the C-terminal region 286-300 of the query sequence. The ATP binding site residues 21 to 29 is highly conserved; seven out of nine amino acid residues are identical between the query sequence and the template (1RDQE). The key residues lysine 44 and tyrosine 188/199 are conserved in most templates, while Ser 177/181 are matched with the template 1PHKA.
Modelling of IKK-β kinase domain
The 100 initial models generated by Modeller9v7 resulted in normalised Discrete Optimized
Protein Energy (Shen and Sali, 2006) The analysis of peptide backbone dihedral angles based on the Ramachandran plot (table 1) showed that experimental structures had a higher proportion of residues in the allowed regions, than both of the models with the exception of 3DTC. The differences were, however minor.
The comparison of the initial model with the SAMD model in figure 2a showed that the perresidue DOPE score was improved for every residue in the model except for the last three Cterminal residues. The most apparent structural differences were visible in the N-terminal α-helix up to residue Arg20, in the antiparallel β-sheet from His33 to Ile43, in a helix-loophelix motif from Gln110 to Ile122, in the loop Gly156 to Arg159 and in a C-terminal disordered region starting from Gln278.
Overall the SAMD simulation resulted in a more compact well defined structure, which was significantly protein-like as evidenced by the MolProbity score.
IKK-β structure
The model for IKK-β showed the typical two-lobe structure (figure 3a) of eukaryotic serine/threonine and tyrosine protein kinases analysed by Hanks & Hunter (Hanks and Hunter, 1995 ) with a C-terminal lobe rich in α-helices and an N-terminal lobe rich in β-sheet secondary structures. The deep cleft between the two lobes is the site of ATP binding, while the peptide substrate is known to bind to the C-lobe. The location of typical structural features reviewed by Huse and Kuriyan (2002) has been highlighted in figure 3a , such as the phosphate binding (P-) loop from Gly22 to Val29, the only α-helix in the N-lobe from Arg53
to Arg67 (αC helix) and the activation loop from Leu167 to Tyr188. The αC helix is known to undergo positional changes due to regulation of the kinase activity, e.g. in cyclindependent kinases (Debondt et al., 1993; Jeffrey et al., 1995) , where the αC helix undergoes a rotation due to the binding of cyclin. The activation loop contains residues Ser177, Ser181
that are phosphorylated as part of the activation mechanism (Lallena et al., 1999) as well as Tyr188 and Tyr199 (Darwech et al., 2010b; Huang et al., 2003) with Tyr199 being outside the commonly known activation loop. In the model shown in figure 3a the activation loop points away from the ATP binding site, which is characteristic of the active form of the kinase, while in the inactive form the activation loop adopts a conformation that impedes the binding of ATP and the peptide substrate (Hubbard et al., 1994) .
A long C-terminal segment from Leu265 to Phe300 is unstructured and remains unstructured in conformations encountered during molecular dynamics simulations (see below). .
ATP binding
The adenine base of the ATP molecule was mainly bound via hydrophobic contacts to the protein provided by Leu21, Gly22, Gly24, Val29, Ala42, Tyr98 and Ile165 (figure 3b and 
Conformational dynamics of IKK-β
The conformational dynamics at room temperature in the vicinity of the SAMD-refined analysis. Based on our observation of a long C-terminal segment that lacks secondary structure we recommend crystallisation of a reduced length kinase domain from Ala14 to Leu265.
Comparison of the trajectories of the protein with and without ATP (figure 4) shows that the RMSD values with respect to the starting structure are overall similar. During the first 5 ns there was a sharp increase in the RMSD for the apo-enzyme reflecting the structural adaption to the removal of ATP, but there was a tendency for the apo-enzyme to adopt lower RMSD values than the holo-enzyme. It should be noted, however, that the RMSD was calculated with respect to the beginning of the simulation. While the RMSD is indicative of the deviation of the simulation from the starting structure, the root mean square fluctuation (RMSF) can capture the equilibrium dynamics. In order to exclude the fluctuations at the beginning of the simulation due to the removal of ATP for the apo-enzyme, the RMSF between 10 and 80 ns was calculated (figure 5). The average RMSF per residue shown in figure 5a revealed that the holo-enzyme structure was overall more stable than the structure of the apo-enzyme. Residues that showed a particular high structural fluctuation were 9, 83
and 114. The mapping of the RMSF onto the 3D structure using a colour gradient from blue (low RMSF) to red (high RMSF) revealed similarly that the holo-enzyme shows overall less fluctuations apart from a segment of the αC helix from Arg47 to Glu61, that was in contact with Pro88-Pro92, which showed also high RMSF values ( figure 5b and c) . The apo-enzyme showed fluctuations throughout the structure, but not in the aforementioned segments. It is, therefore, tempting to speculate that the high RMSF values in a few segments of the holoenzyme indicate conformational fluctuations that bring ATP into close contact with the protein phosphorylation substrate. The same observations with regards to RMSF were made in repeated simulations (data not shown).
Given the high RMSD with respect to the starting structure for both apo-and holo-enzyme, it is clear that the final outcome of the comparative modelling process described above is not the major conformation of IKK-β in solution. A cluster analysis of the trajectory resulted in the identification of three conformations in case of holo-enzyme and four conformations in case of the apo-enzyme (table 2) .
In both cases there were two predominant conformations, which were encountered in 74% of the trajectory for the holo-enzyme and in 83.5% of the trajectory for the apo-enzyme. These conformations were not identical, as the protein backbone RMSD between them was 0.55 nm. Visual comparison of these two conformations in figure 6a and 6b (leftmost structure)
showed that there were subtle differences throughout the structure but most apparently in the orientation of an N-terminal segment and an anti-parallel beta-hairpin from Asp78 to Arg95, that does not show any beta-structure in the holo-enzyme. The two minor conformations showed similar differences, which were overall less pronounced resulting in an RMSD of 0.38 nm between ATP2 and noATP2. The overlay of all three or four conformations of the holo-and apo-enzyme respectively with the comparative model (figure 6, right hand side)
showed that the holo-form underwent major structural changes in the N-lobe, while the structural changes in the C-lobe were more subtle. The apo-form showed significant structural changes throughout, which would be expected as the protein structure was modelled with the ATP cofactor bound.
It should be noted that the simulation time of 80 ns limits the conformational changes to small scale motions in the vicinity of the starting structure, which nevertheless allow the exploration of side-chain movements and loop flexibility that is in agreement with NMR experiments (Almond et al., 2007) and may critically influence ligand binding.
Binding site prediction
Given the structural changes observed, we investigated, if the ATP binding site was retained in the apo-form and if other binding sites for potential allosteric modulators are available using computational solvent mapping . Figure 7 shows the predicted binding sites for the two major conformations of the apo-enzyme. In the most populated conformation noATP1 (figure 7a) the ATP binding site is mapped out by clusters of solvent molecules ranked at place two and four. In the conformation noATP2 ( figure 7b ) the highest ranked binding sub-site one does not coincide with the original ATP binding site, while subsite two retains the position shown in figure 7a . It is possible that the conformation noATP2
represents a pre-ATP binding state, which allows ATP interaction at sub-sites one and two followed by a conformational change that allows ATP to slip into its deep binding pocket. An additional highly ranked binding site of conformation noATP1 (figure 7a) was predicted by solvent clusters one and three at a location distant from ATP binding. This binding site is formed by the helix Thr200-Gly218 and residues Lys254/Ser258 from a short C-terminal helix. Pro260, Tyr261 and Asn263 also contribute to the binding site. The binding site was partially retained in the conformation noATP2, but based on lower ranked solvent clusters.
Interestingly, this binding site was not seen in the ATP bound conformations (data not shown), thus it may be an allosteric binding site that could be targeted with ligands that lock IKK-β in an ATP-free inactive conformation. Another possibility for the design of novel inhibitors may be targeting the highly ranked sub-sites one and two in the pre-ATP conformation.
Conclusion
In the absence of a crystal-or NMR-structure of the IKK-β kinase, a comparative model was developed and it was demonstrated how the model accuracy can be improved by simulated annealing MD simulations. Importantly, the ATP co-factor was included in the modelling process, which renders the present structure an ideal starting point for receptor-based virtual screening efforts as well as rational drug-design. The location of structural elements and residues interacting with ATP is commensurate with the structural details of other Ser/Thr kinases known from x-ray crystallography confirming the accuracy of the present model. In addition the conformational dynamics of the apo-form of the kinase showed the emergence of additional binding sites that could lead to the design of new isosteric as well as allosteric modulators. (Sanner, 1999; Sanner et al., 1996) . (c) 2D representation of the ATP-protein interaction. Bonds within the ATP ligand are shown in purple. This figure was made with LigPlot (Wallace et al., 1995) . 
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